| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41568-020-0266-X |
| P698 | PubMed publication ID | 32528185 |
| P50 | author | Jack Cuzick | Q21005493 |
| Kara L. Britt | Q37370390 | ||
| Kelly-Anne Phillips | Q41368487 | ||
| P2860 | cites work | Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis | Q24617063 |
| A large-scale candidate gene association study of age at menarche and age at natural menopause | Q24619411 | ||
| Mammographic density is related to stroma and stromal proteoglycan expression | Q24803332 | ||
| Oestrogen exposure and breast cancer risk | Q24803498 | ||
| Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis | Q26773464 | ||
| Relevance of tumor-infiltrating lymphocytes in breast cancer | Q26795598 | ||
| The timing of the age at which natural menopause occurs | Q26822580 | ||
| Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies | Q26824426 | ||
| Mammary stem cells and the differentiation hierarchy: current status and perspectives | Q27003345 | ||
| Sugar-sweetened beverage consumption and age at menarche in a prospective study of US girls | Q27300799 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers | Q28067154 | ||
| Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies | Q28074177 | ||
| Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis | Q28085555 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer | Q28142158 | ||
| Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk | Q28168742 | ||
| Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status | Q28176257 | ||
| Moderate alcohol intake and cancer incidence in women | Q28236401 | ||
| Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies | Q28280957 | ||
| Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 | ||
| Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland | Q28573752 | ||
| Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
| Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies | Q30248475 | ||
| Genomic signature of parity in the breast of premenopausal women | Q64106252 | ||
| The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study | Q64115146 | ||
| 10-year performance of four models of breast cancer risk: a validation study | Q64115284 | ||
| Risk for breast cancer development determined by mammographic parenchymal pattern | Q67443501 | ||
| Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
| Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study | Q72241677 | ||
| Cancer in developing countries | Q72284414 | ||
| Incidence of female breast cancer among atomic bomb survivors, 1950-1985 | Q72421675 | ||
| Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction | Q72752023 | ||
| Evidence for a secular trend in menopausal age: a population study of women in Gothenburg | Q79308865 | ||
| Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990 | Q79326463 | ||
| Absolute risk models for subtypes of breast cancer | Q79827582 | ||
| Ethnicity and breast cancer: factors influencing differences in incidence and outcome | Q81527448 | ||
| Tamoxifen and risk of contralateral breast cancer among women with inherited mutations in BRCA1 and BRCA2: a meta-analysis | Q85237288 | ||
| Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density | Q88282837 | ||
| Estrogen receptor subtypes dictate the proliferative nature of the mammary gland | Q88321815 | ||
| Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial | Q89592770 | ||
| The Immune Microenvironment of Breast Cancer Progression | Q90133583 | ||
| Breast cancer statistics, 2019 | Q90435626 | ||
| Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk | Q90439909 | ||
| Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom) | Q90590091 | ||
| Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial | Q91989928 | ||
| Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool | Q92102602 | ||
| Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017 | Q92173434 | ||
| A systematic review and quality assessment of individualised breast cancer risk prediction models | Q92199197 | ||
| International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation | Q93012417 | ||
| Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia | Q93025306 | ||
| Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence | Q93043410 | ||
| Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update | Q93073081 | ||
| A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density | Q93103805 | ||
| Consumer and clinician perspectives on personalising breast cancer prevention information | Q93176217 | ||
| Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk | Q93367394 | ||
| Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers | Q37090813 | ||
| Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells--implications for pregnancy-induced protection against breast cancer | Q37109686 | ||
| Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers | Q37122297 | ||
| Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis | Q37135273 | ||
| Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model | Q37172219 | ||
| Australian clinicians and chemoprevention for women at high familial risk for breast cancer | Q37204722 | ||
| Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells | Q37208782 | ||
| Association of adiposity genetic variants with menarche timing in 92,105 women of European descent | Q37276250 | ||
| Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro | Q37358267 | ||
| Risk factors for young-onset invasive and in situ breast cancer. | Q37429187 | ||
| Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies | Q37594136 | ||
| Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum | Q37639092 | ||
| SCA-1 Labels a Subset of Estrogen-Responsive Bipotential Repopulating Cells within the CD24+ CD49fhi Mammary Stem Cell-Enriched Compartment | Q37644732 | ||
| Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic. | Q37681706 | ||
| Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results | Q37683663 | ||
| JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention. | Q37705086 | ||
| Genetic modifiers of CHEK2*1100delC-associated breast cancer risk | Q37739048 | ||
| Physical activity and breast cancer prevention | Q37813058 | ||
| Rising incidence of breast cancer: relationship to stage and receptor status | Q38063717 | ||
| Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology? | Q38225334 | ||
| EDAC: Epithelial defence against cancer-cell competition between normal and transformed epithelial cells in mammals | Q38492798 | ||
| Menstrual cycle length preceding menopause in relation to age at menopause | Q38502496 | ||
| The regulation of immune cell trafficking by the extracellular matrix | Q38550053 | ||
| Adiposity and cancer risk: new mechanistic insights from epidemiology | Q38553013 | ||
| St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment | Q38676979 | ||
| Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers | Q38717239 | ||
| Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline. | Q38724093 | ||
| Why invest, and what it will take to improve breastfeeding practices? | Q38730664 | ||
| Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review | Q38775675 | ||
| Moderate-vigorous recreational physical activity and breast cancer risk, stratified by menopause status: a systematic review and meta-analysis | Q38990230 | ||
| BI-RADS® fifth edition: A summary of changes | Q38993876 | ||
| Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history. | Q39009545 | ||
| Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women | Q39076835 | ||
| Out-RANKing BRCA1 in Mutation Carriers. | Q39095660 | ||
| Assessing and managing breast cancer risk: clinicians' current practice and future needs | Q39164029 | ||
| Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. | Q39263736 | ||
| Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers | Q39314538 | ||
| Regulation of the Immune System by Laminins | Q39419150 | ||
| Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study | Q39540042 | ||
| RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. | Q39670403 | ||
| Socioeconomic status in relation to early menarche among black and white girls | Q40016138 | ||
| Projecting individualized absolute invasive breast cancer risk in African American women | Q40149673 | ||
| Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist | Q40202330 | ||
| Cohort profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA). | Q40343406 | ||
| Global trends in breast cancer incidence and mortality 1973-1997. | Q40441994 | ||
| Cumulative risks and cessation of exclusive breast feeding: Australian cross-sectional survey | Q40856260 | ||
| Lobular neoplasia. Long term risk of breast cancer and relation to other factors | Q41089753 | ||
| Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants. | Q41093416 | ||
| Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction | Q41195564 | ||
| Prenatal smoking and age at menarche: influence of the prenatal environment on the timing of puberty. | Q41293407 | ||
| Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease? | Q41368391 | ||
| The WISDOM Study: breaking the deadlock in the breast cancer screening debate | Q41701590 | ||
| The rise and fall of infectious diseases: Australian perspectives, 1914-2014. | Q42204716 | ||
| The heritability of mammographically dense and nondense breast tissue | Q43480606 | ||
| Serum hormones and the alcohol-breast cancer association in postmenopausal women | Q43595452 | ||
| Age at menarche in the Canadian population: secular trends and relationship to adulthood BMI. | Q43970598 | ||
| Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. | Q44114229 | ||
| First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial | Q44146948 | ||
| Nurses' health study: log-incidence mathematical model of breast cancer incidence | Q44198064 | ||
| Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. | Q44265649 | ||
| A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers | Q44463946 | ||
| Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial | Q44659430 | ||
| Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007. | Q44967246 | ||
| Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis | Q45149732 | ||
| Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors | Q45187321 | ||
| Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study | Q46135272 | ||
| Factors associated with age at natural menopause in a multiethnic sample of midlife women | Q46316948 | ||
| Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium | Q47190168 | ||
| Contemporary Hormonal Contraception and the Risk of Breast Cancer. | Q47277235 | ||
| Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status | Q47324684 | ||
| Adult weight change and risk of postmenopausal breast cancer | Q47330282 | ||
| Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study | Q47388619 | ||
| A Survey among Breast Cancer Specialists on the Low Uptake of Therapeutic Prevention with Tamoxifen or Raloxifene | Q47736022 | ||
| Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development. | Q47831545 | ||
| Association study of the oestrogen signalling pathway genes in relation to age at natural menopause | Q47884263 | ||
| Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition | Q47984396 | ||
| Menstrual and reproductive factors and risk of breast cancer: A case-control study in the Fez region, Morocco | Q48234986 | ||
| Exemestane for breast-cancer prevention in postmenopausal women. | Q48657440 | ||
| Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women | Q30501421 | ||
| Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger | Q30541773 | ||
| Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. | Q30620197 | ||
| Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data | Q30620889 | ||
| Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies | Q30657567 | ||
| Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease | Q30705774 | ||
| Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. | Q30980873 | ||
| Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials | Q30982699 | ||
| Reproductive risk factors and breast cancer subtypes: a review of the literature | Q33632008 | ||
| An investigation of breast cancer risk factors in Cyprus: a case control study | Q33667724 | ||
| Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs' attitudes | Q33722922 | ||
| Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk | Q33729336 | ||
| Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2. | Q33737286 | ||
| Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance | Q33739374 | ||
| Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling | Q33739919 | ||
| Collagen density promotes mammary tumor initiation and progression | Q33845553 | ||
| Long-term metformin use is associated with decreased risk of breast cancer. | Q33873130 | ||
| Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism | Q33911150 | ||
| Gestational weight gain and daughter's age at menarche | Q33944698 | ||
| Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR | Q33974258 | ||
| Oral bisphosphonate use and breast cancer incidence in postmenopausal women | Q34049239 | ||
| Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms | Q34100410 | ||
| A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis | Q34106263 | ||
| Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer | Q34110074 | ||
| A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes | Q34115258 | ||
| Oral contraceptive use and breast cancer: a prospective study of young women | Q34134707 | ||
| Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies | Q34151528 | ||
| Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial | Q34208463 | ||
| Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways | Q34248904 | ||
| Differentiation of the mammary gland and susceptibility to carcinogenesis | Q34250746 | ||
| Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force | Q34339445 | ||
| Prevalence of mammographically dense breasts in the United States | Q34354391 | ||
| Metformin: an old but still the best treatment for type 2 diabetes | Q36715464 | ||
| Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers | Q36742577 | ||
| Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer. | Q36759471 | ||
| Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium | Q36902954 | ||
| Factors related to age at natural menopause: longitudinal analyses from SWAN. | Q36974853 | ||
| Mammographic density and risk of breast cancer by mode of detection and tumor size: a case-control study | Q37018080 | ||
| Pregnancy and the risk of breast cancer | Q37018385 | ||
| Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials. | Q48717652 | ||
| Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction. | Q49964811 | ||
| Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. | Q50194011 | ||
| Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. | Q50696322 | ||
| Use of bisphosphonates and risk of breast cancer. | Q51514495 | ||
| A breast cancer prediction model incorporating familial and personal risk factors. | Q52000310 | ||
| Early stress predicts age at menarche and first birth, adult attachment, and expected lifespan. | Q52040742 | ||
| Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. | Q52274948 | ||
| Physical activity and risk of breast cancer: a meta-analysis of prospective studies. | Q53111772 | ||
| Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. | Q53417183 | ||
| Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer | Q54089896 | ||
| Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | Q56245789 | ||
| Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study | Q56669882 | ||
| Breast cancer and hormone-replacement therapy: the Million Women Study | Q56863703 | ||
| Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC) | Q58613780 | ||
| Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study | Q59288218 | ||
| Secular trends in age at menarche in women in the UK born 1908-93: results from the Breakthrough Generations Study | Q59291440 | ||
| Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes | Q62583133 | ||
| Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants | Q64004339 | ||
| Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies | Q64101448 | ||
| Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2 | Q34384153 | ||
| Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. | Q34458235 | ||
| Pregnancy-associated breast cancer and metastasis. | Q34504760 | ||
| Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. | Q34513749 | ||
| Epidemiology of basal-like breast cancer | Q34639174 | ||
| Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. | Q34727905 | ||
| Effect of acute exercise on prostate cancer cell growth | Q34825681 | ||
| Childhood experience, interpersonal development, and reproductive strategy: and evolutionary theory of socialization | Q34974717 | ||
| Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older | Q35023437 | ||
| Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression | Q35071581 | ||
| Risk factor modification and projections of absolute breast cancer risk | Q35090578 | ||
| Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme | Q35441054 | ||
| Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers | Q35523236 | ||
| Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies | Q35605749 | ||
| Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer | Q35613614 | ||
| Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk | Q35797100 | ||
| Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer | Q35996692 | ||
| Gene-panel sequencing and the prediction of breast-cancer risk | Q36175072 | ||
| Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies | Q36368636 | ||
| Use of statistics to assess the global burden of breast cancer | Q36375357 | ||
| Parity and breastfeeding are protective against breast cancer in Nigerian women. | Q36494156 | ||
| Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis | Q36507079 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Odds per adjusted standard deviation: comparing strengths of associations for risk factors measured on different scales and across diseases and populations | Q36591738 | ||
| Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology | Q36615101 | ||
| Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects | Q36615701 | ||
| Assessing the performance of prediction models: a framework for traditional and novel measures | Q36617895 | ||
| Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2 | Q36618998 | ||
| Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial | Q36634556 | ||
| Maternal pre-pregnancy BMI, gestational weight gain, and age at menarche in daughters | Q36639726 | ||
| Hormonal content and potency of oral contraceptives and breast cancer risk among young women | Q36647837 | ||
| iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management | Q36678510 | ||
| Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study | Q36678729 | ||
| The BOADICEA model of genetic susceptibility to breast and ovarian cancer | Q36695832 | ||
| P577 | publication date | 2020-06-11 | |
| P1433 | published in | Nature Reviews Cancer | Q641657 |
| P1476 | title | Key steps for effective breast cancer prevention |
Search more.